Clinical Nutrition For Cancer Care Market Report 2026

Clinical Nutrition For Cancer Care Market Overview

• Clinical Nutrition For Cancer Care market size has reached to $5.16 billion in 2025 • Expected to grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 4.6% • Growth Driver: Cancer Prevalence Is Driving Growth In Clinical Nutrition For Cancer Care Market • Market Trend: Data-Driven And Genomics-Based Approaches Transforming Personalized Cancer Care • North America was the largest region in 2025.

What Is Covered Under Clinical Nutrition For Cancer Care Market?

Clinical nutrition for cancer care refers to the specialized dietary support and interventions tailored to meet the nutritional needs of cancer patients throughout their treatment journey. It involves the provision of personalized nutrition plans aimed at managing symptoms, optimizing treatment outcomes, and improving the overall quality of life for individuals undergoing cancer therapy. The main types of clinical nutrition for cancer care are oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to the intake of food and fluids by mouth to supply the body with essential nutrients, crucial for supporting individuals undergoing cancer treatment. It is for cancer types such as head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and others, with age groups of adult, and pediatric. Clinical nutrition for cancer care is provided by sales channels such as online, retail, and institutional sales.

What Is The Clinical Nutrition For Cancer Care Market Growth Forecast?

The clinical nutrition for cancer care market size is expected to see steady growth in the next few years. It will grow to $6.5 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing focus on personalized oncology care, rising demand for high-protein and immune-support nutrition, expansion of outpatient cancer treatment models, growing adoption of digital nutrition monitoring tools, increasing emphasis on quality-of-life improvement during cancer therapy. Major trends in the forecast period include increasing adoption of personalized nutrition plans for cancer patients, rising use of specialized enteral and parenteral formulations, growing integration of nutritional monitoring technologies, expansion of home-based clinical nutrition support, enhanced focus on symptom-specific nutritional interventions.

Global Clinical Nutrition For Cancer Care Market Segmentation

1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas 2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types 3) By Age Group: Adult, Pediatric 4) By Sales Channel: Online, Retail, Institutional Sales Subsegments: 1) By Oral Nutrition: Protein-Rich Supplements, Carbohydrate-Rich Supplements, Fat-Rich Supplements, Vitamins And Mineral Supplements, Caloric Supplements, Fiber-Enriched Supplements 2) By Parenteral Nutrition: Amino Acids, Carbohydrates, Lipids, Electrolytes And Micronutrients, Intravenous Fat Emulsions, Trace Elements And Vitamins 3) By Enteral Feeding Formulas: Standard Enteral Feeding Formulas, High-Protein Enteral Formulas, High-Calorie Enteral Formulas, Diabetic Enteral Formulas, Elemental Enteral Formulas, Specialized Enteral Formulas

What Is The Driver Of The Clinical Nutrition For Cancer Care Market?

The rising prevalence of cancer is expected to propel the growth of the clinical nutrition for cancer care market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rise in cancer cases is attributed to increased life expectancy, making a larger aging population more susceptible to cancer. Clinical nutrition for cancer care is used to provide specialized dietary management and nutritional support tailored to the unique needs of cancer patients, aiming to optimize treatment outcomes. For instance, in February 2024, according to the World Health Organization, a US-based intergovernmental organization, approximately 35 million new cancer cases were predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the clinical nutrition for cancer care industry.

Key Players In The Global Clinical Nutrition For Cancer Care Market

Major companies operating in the clinical nutrition for cancer care market are Abbott Nutrition, Baxter International Inc., B Braun Melsungen AG, Nestle Health Science S A, Danone Nutricia, Hormel Health Labs, Evonik Industries AG, Otsuka Holdings Co Ltd, Koninklijke DSM N V, Glanbia plc, Meiji Holdings Company Ltd, Victus Inc., Global Health Products Inc., Fresenius Kabi AG, Perrigo Company plc, Arla Foods Ingredients Group P S, Kerry Group plc, Lonza Group AG, Ajinomoto Co Inc., Yakult Honsha Co Ltd, Rousselot BV, Tate Lyle plc, ADM Human Nutrition, Vitaflo International Ltd, Smartfish AS, Medtrition Inc.

Global Clinical Nutrition For Cancer Care Market Trends and Insights

Major companies operating in the clinical nutrition for cancer care market are focusing on leveraging data-driven approaches and advanced genomic profiling to deliver personalized cancer care, improve treatment outcomes, and enhance patient-specific therapy selection. Advanced genomic profiling is the comprehensive analysis of a patient’s genetic material to identify mutations and biomarkers that guide personalized cancer diagnosis, treatment, and prognosis. For instance, in December 2024, Aster DM Healthcare, an UAE-based healthcare provider, launched Precision Oncology, a platform offering personalized cancer care through comprehensive genomic analysis, biomarker identification, and data-driven treatment recommendations. The initiative aims to enable tailored therapy plans, optimize clinical decision-making, and improve overall patient outcomes by integrating advanced diagnostics with precision medicine strategies.

What Are Latest Mergers And Acquisitions In The Clinical Nutrition For Cancer Care Market?

In January 2024, Danone S.A., a France-based food-products corporation, partnered with Resilience to develop a groundbreaking nutrition and oncology module integrated into Resilience's digital oncology solution. This partnership aims to provide better nutritional care for patients with cancer by addressing cancer-related malnutrition, which affects up to 70% of cancer patients. Resilience, a US-based digital oncology company, provides clinical nutrition support for cancer patients.

Regional Outlook

North America was the largest region in the clinical nutrition for cancer care market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Nutrition For Cancer Care Market?

The clinical nutrition for cancer care market consists of sales of clinical nutrition products such as high-protein supplements and dietary supplements rich in antioxidants, vitamins, and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Nutrition For Cancer Care Market Report 2026?

The clinical nutrition for cancer care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for cancer care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.